The Robotic Prostatectomy Marked the Start of the
Hugo™ RAS System Global Patient Registry
DUBLIN, June 22, 2021 /CNW/ -- Medtronic plc (NYSE:MDT),
the global leader in medical technology, today announced the first
patient procedure with the Hugo™ robotic-assisted surgery (RAS)
system. The robotic prostatectomy was performed June 19 by urological surgeon Ruben Olivares, M.D., at Clínica Santa Maria in
Santiago, Chile.
The first patient procedure marks the beginning of the Hugo RAS
system patient registry, which will collect clinical data to
support regulatory submissions around the world.
A modular, multi-quadrant platform designed for a broad range of
surgical procedures, the Hugo RAS system combines wristed
instruments, 3D visualization, and a powerful surgical video
capture option in Touch Surgery™ Enterprise with dedicated support
teams specializing in robotics program optimization, service, and
training.
"I'm proud to have performed the very first clinical procedure
with the Hugo RAS system," said Dr. Olivares. "From the open
console and modular platform to the instrumentation I know and
trust, this innovative system is truly a partner in the OR. I feel
energized by the possibility the Hugo RAS system brings to patients
and clinicians and am honored to help pave the way for future
surgeons, being able to offer a minimal invasive alternative on a
regular basis."
With the Hugo RAS system, Medtronic is building on its
decades-long history of bringing the benefits of minimally invasive
surgery (MIS) to more patients around the world. With MIS, patients
experience fewer complications, shorter hospital stays, and faster
return to normal activities.1-3,†
RAS delivers the benefits of MIS, yet accounts for less than
three percent of all surgeries performed today,4 mostly
due to historic cost and utilization barriers that put it out of
reach for many hospitals.5 A global leader in open and
laparoscopic surgery, Medtronic designed the Hugo RAS system to
help improve robotics economics and utilization — based on input
from hundreds of clinicians and hospital executives.
"Today, with the start of our Hugo RAS system patient registry,
we're taking an exciting step forward to bring the benefits of
robotic-assisted surgery to more patients in more places," said
Megan Rosengarten, president of the
Surgical Robotics business, which is part of the Medical Surgical
Portfolio at Medtronic. "That's possible thanks to our shared
vision with Clínica Santa Maria, the first institution to join our
Partners in Possibility Program, a group of pioneering hospitals
that will be among the first in the world to use the Hugo RAS
system in support of our patient registry."
Clínica Santa María has more than 10 years of experience in
robotic surgery, and today the clinic incorporates this new
technology to continue offering its patients world-class surgical
options, with high standards of quality and safety.
"We are committed to providing the most advanced and innovative
care to our patients. In this context, robotic surgery is a
minimally invasive alternative that we have been performing with
excellent results for more than a decade, with a total of more than
2,000 interventions of this type to date," said Martín Manterola,
chief executive officer, Clínica Santa María. "The alliance with
Medtronic and the incorporation of the Hugo™ RAS system to our
center places us as the first health institution in the world to
use this new technology and is a milestone that reinforces the
dedication and experience of our medical team."
The Hugo RAS system is not cleared or approved in the U.S. or
Europe. Regulatory requirements of
individual countries and regions will determine availability and
approval or clearance timelines. Touch Surgery Enterprise is
not intended to direct surgery, or aid in diagnosis or treatment of
a disease or condition.
About Medtronic
Medtronic plc (www.medtronic.com),
headquartered in Dublin, Ireland,
is among the world's largest medical technology, services and
solutions companies – alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 90,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
†Compared to open surgery.
1 Fitch K, Engel T, Bochner A. Cost differences
between open and minimally invasive surgery. Managed Care.
2015 Sep;24(9):40–8.
2 Tiwari MM, Reynoso JF, High R, Tsang AW,
Oleynikov D. Safety, efficacy, and cost effectiveness of common
laparoscopic procedures. Surg
Endosc. 2011;25(4):1127-1135.
3 Roumm AR, Pizzi L, Goldfarb NI, Cohn H. Minimally
invasive: minimally reimbursed? An examination of six laparoscopic
surgical procedures. Surg Innovation.
2005;12(3):261–287.
4 Based on internal estimates and Medtronic report,
FY20 market model: procedural volume data.
5 Based on internal report prepared by Consumer
Dynamics: quantitative research with U.S. and European surgeons and
hospital executives. March 21,
2020.
Contacts:
|
|
|
|
Gary
Jeanfaivre
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-203-833-2104
|
+1-763-505-4626
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/first-procedure-in-the-world-with-medtronic-hugo-robotic-assisted-surgery-system-performed-at-clinica-santa-maria-in-chile-301316903.html
SOURCE Medtronic plc